Tolerability and Safety of Sublingual Immunotherapy in Patients with Tree Pollen Allergy in Daily Practice—An Open, Prospective, Non-Interventional Study.

MLA

Owenier, Christoph, et al. “Tolerability and Safety of Sublingual Immunotherapy in Patients with Tree Pollen Allergy in Daily Practice—An Open, Prospective, Non-Interventional Study.” Journal of Clinical Medicine, vol. 12, no. 17, Sept. 2023, p. 5517. EBSCOhost, https://doi.org/10.3390/jcm12175517.

APA

Owenier, C., Barnowski, C., Leineweber, M., Yu, D., Verhagen, M., & Distler, A. (2023). Tolerability and Safety of Sublingual Immunotherapy in Patients with Tree Pollen Allergy in Daily Practice—An Open, Prospective, Non-Interventional Study. Journal of Clinical Medicine, 12(17), 5517. https://doi.org/10.3390/jcm12175517

Chicago

Owenier, Christoph, Cornelia Barnowski, Margret Leineweber, Donghui Yu, Marjan Verhagen, and Andreas Distler. 2023. “Tolerability and Safety of Sublingual Immunotherapy in Patients with Tree Pollen Allergy in Daily Practice—An Open, Prospective, Non-Interventional Study.” Journal of Clinical Medicine 12 (17): 5517. doi:10.3390/jcm12175517.